• OPEN AN ACCOUNT
Indian Indices
Sensex
74,781.76 -120.83
( -0.16%)
Global Indices
Nasdaq
52,596.82 511.72
(0.98%)
Dow Jones
7,678.62 65.92
(0.87%)
Hang Seng
63,517.44 -493.90
(-0.77%)
Nikkei 225
10,692.77 42.33
(0.40%)
Forex
USD-INR
95.45 0.39
(0.41%)
EUR-INR
110.95 0.35
(0.32%)
GBP-INR
129.16 0.36
(0.28%)
JPY-INR
0.62 0.00
(0.09%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
93.2373503
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
138.81
441957.5
EPS(TTM)
Face Value()
Div & Yield %
13.27
1
0.87
 

Parshwanath Corporation reports standalone net loss of Rs 0.36 crore in the March 2026 quarter
May 29,2026
Net loss of Parshwanath Corporation reported to Rs 0.36 crore in the quarter ended March 2026 as against net profit of Rs 0.01 crore during the previous quarter ended March 2025. Sales remain constant at Rs 0.12 crore in the quarter ended March 2026 and also during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 0.03 crore in the year ended March 2026 as against net profit of Rs 0.55 crore during the previous year ended March 2025. Sales declined 11.43% to Rs 0.62 crore in the year ended March 2026 as against Rs 0.70 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.120.12 0 0.620.70 -11
OPM %-416.67-158.33 --87.10-22.86 -
PBDT-0.490.02 PL 0.030.66 -95
PBT-0.490.02 PL 0.030.66 -95
NP-0.360.01 PL -0.030.55 PL